Home Surmodics

Surmodics

Avess Study: 6-Month Data AV Fistula DCB First-in-Human Study Presented at Viva 2020

AVESS study is a prospective, multi-center, single-arm study to assess the safety and performance of the Avess DCB* when used in the treatment of subjects with obstructive lesions of arteriovenous fistulae (AVF) for hemodialysis.

Pounce Thrombus Retrieval System Receives FDA Approval – Non-Surgical Removal of Thrombi and Emboli from the Peripheral Arterial Vasculature

The Pounce Thrombus Retrieval System is intended for the non-surgical removal of thrombi and emboli from the peripheral arterial vasculature.

SurVeil™ Drug Coated Balloon Receives CE Mark

The SurVeil DCB, a next-generation device that utilizes best-in-class technology in the treatment of peripheral artery disease (PAD), includes a proprietary drug-excipient formulation for a durable balloon coating and is manufactured using an innovative process to improve coating uniformity.

4/23/19: Surmodics Sublime Guide Sheath Receives FDA 510(k) Approval

The highly flexible, proprietary Xtreme® braid-reinforced Sublime guide sheath is designed to resist kinking and maximize strength while retaining a low profile. The sheath will be available in 5Fr and 6Fr diameters, and 120cm and 150cm lengths.

FDA Clearance of a New .018” Low-Profile PTA Balloon Dilation Catheter Reported by Surmodics

4/23/18: The company reports continued progress in R&D whole-product solutions pipeline.